Please enable Javascript
Cailin Conner
Articles by Cailin Conner
Saliva Pepsin Levels Are a Potential Risk Factor for Asthma in Children With Allergic Rhinitis
Cailin Conner
Pulmonology
|
April 26, 2024
Research identified risk factors that may exacerbate asthma in children with allergic rhinitis.
Read More
Study Reports Higher Prevalence of Long COVID in Men With T2D
Cailin Conner
Diabetes
|
April 25, 2024
Men with type 2 diabetes have higher rates of recorded long COVID.
Read More
Cognitive Processing Speed Is Vulnerable to Glucose Fluctuations in Patients With T1D
Cailin Conner
Diabetes
|
April 1, 2024
Patients with T1D face numerous challenges, including cognitive fluctuations.
Read More
Study Suggests Sleep, Mood Disorders May Adversely Affect Asthma Control
Cailin Conner
Asthma
|
April 1, 2024
Individuals with asthma frequently report experiencing subpar sleep quality.
Read More
PPAR Subtype Downregulation Impairs Periodontal Healing in Patients With Type 2 Diabetes
Cailin Conner
Diabetes
|
March 22, 2024
The downregulation of PPAR subtype expression in patients with T2D impairs the healing of periodontal tissues.
Read More
Machine Learning Study Finds Children Exposed to Toxic Air Particularly Vulnerable to Asthma
Cailin Conner
Asthma
|
March 21, 2024
A study used machine learning to examine air toxics associated with asthma symptoms.
Read More
Bariatric Surgery Linked to Better Long-term Glycemic Control Versus Medical, Lifestyle Management
Cailin Conner
Diabetes
|
March 12, 2024
A study assessed the long-term efficacy and safety of bariatric surgery compared with medical/lifestyle management.
Read More
Gas Stoves Emit Nanocluster Aerosol That May Increase Risk of Asthma, Respiratory Illness
Cailin Conner
Asthma
|
March 12, 2024
A study found that cooking on a gas stoves can increase susceptibility to asthma or other respiratory illnesses.
Read More
SGLT2 Inhibitors May Protect Against Diabetic Retinopathy in Patients With T2D
Cailin Conner
Diabetes
|
December 21, 2023
A study investigated whether SGLT2 inhibitors could protect against diabetic retinopathy in patients with type 2 diabetes.
Read More
High BMI Negatively Impacts Patients With COPD and Asthma
Cailin Conner
Asthma
|
December 21, 2023
Body mass index greatly affects the diagnosis and severity of chronic obstructive pulmonary disease and asthma.
Read More
Most Patients Modify Their Type 2 Diabetes Treatment Regimen Within 1 Year of Initiation
Cailin Conner
Diabetes
|
December 19, 2023
A study described changes in antidiabetic medication use after the start of second-line therapy in patients with T2D.
Read More
Benralizumab Allows Safe Reduction of Inhaled Corticosteroid Therapy in Patients With Severe Asthma
Cailin Conner
Asthma
|
December 15, 2023
A study investigated the safety and efficacy of tapering ICS in patients with severe asthma treated with benralizumab.
Read More
Study Compares HSCT Outcomes Among Conditioning Approaches in Patients with SCD
Cailin Conner
Sickle Cell Disease
|
December 11, 2023
Non-myeloablative versus myeloablative conditioning for HSCT varied in engraftment, hospitalization, and GVHD outcomes.
Read More
Cost-Effective Analysis Identifies Allotransplantation as an Equitable Therapy for Pediatric Patients with SCD
Cailin Conner
Sickle Cell Disease
|
December 11, 2023
Allotransplantation had "equitable" cost-efficacy in pediatric patients with sickle cell disease in the United States.
Read More
Phase I Study Reports No Dose-Limiting Toxicities for Recombinant ADAMTS13 in Patients with SCD
Cailin Conner
Sickle Cell Disease
|
December 11, 2023
Recombinant ADAMTS13 treatment exhibited promising safety and efficacy profiles in patients with sickle cell disease.
Read More
Exagamglogene Autotemcel Demonstrates Improved Health-related QOL in Patients with Severe SCD
Cailin Conner
Sickle Cell Disease
|
December 11, 2023
CLIMB SCD-121 data showed exa-cel treatment induced meaningful improvements in health-related quality of life in SCD.
Read More
Phase III Trial of Exagamglogene Autotemcel Meets Primary and Key Secondary Endpoints
Cailin Conner
Sickle Cell Disease
|
December 11, 2023
Exagamglogene autotemcel met primary and key secondary endpoints in the phase III CLIMB-SCD-121 trial on sickle cell disease.
Read More
Changes in Lipidome of Hyperuricemic and Gout Patients Has Significant Effect on Lipid Metabolism
Cailin Conner
Gout
|
December 12, 2023
A study found notable lipid profile changes in hyperuricemia and early-onset gout.
Read More
Nrf2 Activation May Reduce Joint Inflammation in Patients With Gout
Cailin Conner
Gout
|
December 9, 2023
Pharmacologic activation of Nrf2 alleviates gout by inhibiting oxidative stress, reducing joint inflammation.
Read More
Metabolic Syndrome Associated With Increased Risk of Hyperuricemia in Women
Cailin Conner
Gout
|
December 8, 2023
Metabolic syndrome is strongly linked to hyperuricemia in both genders, especially in women.
Read More
Load More